Cresco Labs | SUNNYSIDE Stock
Ticker - CRLBF

Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Investment analysts at Echelon Wealth Partners increased their FY2024 earnings per share estimates for Cresco Labs in a research report issued to clients and investors on Wednesday, March 13th. Echelon Wealth Partners analyst A. Semple now forecasts that the company will earn ($0.07) per share for the

Cresco Labs (OTCMKTS: CRLBF), a leading multistate operator in the cannabis industry, faced significant financial hurdles in 2023, recording a net loss of $180 million. Despite encountering obstacles such as market exits and a failed merger, the company remains resilient. It is poised to explore emerging opportunities within the cannabis landscape. Throughout 2023, Cresco Labs

Cresco Labs (OTCMKTS:CRLBF – Get Free Report) had its target price lifted by equities research analysts at Roth Mkm from $1.75 to $2.00 in a research report issued on Thursday, Benzinga reports. The firm presently has a “neutral” rating on the stock. Roth Mkm’s price objective would suggest a potential upside of 5.82% from the

Cresco Labs (OTCMKTS:CRLBF) just reported results for the fourth quarter of 2023. Cresco Labs reported earnings per share of 1 cent. This was above the analyst estimate for EPS of -2 cents.The company reported revenue of $188.24 million.This was 3.53% better than the analyst estimate for revenue of $181.82 million. InvestorPlace Earnings is a project

Read More

Cresco Labs CRLBF just reported results for the fourth quarter of 2023. Cresco Labs reported earnings per share of 1 cent. This was above the analyst estimate for EPS of -2 cents.The company reported revenue of $188.24 million.This was 3.53% better than the analyst estimate for revenue of $181.82 million. InvestorPlace Earnings is a project